PBPK Modeling of Entrectinib and Its Active Metabolite to Derive Dose Adjustments in Pediatric Populations Co‐Administered with CYP3A4 Inhibitors
Article in Clinical Pharmacology & Therapeutics (July 2024)
The most recent citing publications are shown below. View all 36 publications that cite this research output on Dimensions.
Article in Clinical Pharmacology & Therapeutics (July 2024)
Article in Clinical Pharmacology & Therapeutics (June 2024)
Article in Cancer Chemotherapy and Pharmacology (May 2024)